Page 1312 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

59. Perdomo J, Yan F, Ahmadi Z, Jiang XM, Stocker R, Chong BH. thrombocytopenia: a systematic review and meta-analysis.
Quinine-induced thrombocytopenia: drug-dependent GPIb/IX Blood. November 15, 2012;120(20):4160-4167.
antibodies inhibit megakaryocyte and proplatelet production in 76. Pouplard C, Amiral J, Borg JY, Laporte-Simitsidis S, Delahousse
vitro. Blood. June 2, 2011;117(22):5975-5986. B, Gruel Y. Decision analysis for use of platelet aggregation
60. Arepally GM, Mayer IM. Antibodies from patients with test, carbon 14-serotonin release assay, and heparin-platelet
heparin-induced thrombocytopenia stimulate monocytic factor 4 enzyme-linked immunosorbent assay for diagnosis of
cells to express tissue factor and secrete interleukin-8. Blood. heparin-induced thrombocytopenia. Am J Clin Pathol. May
August 15, 2001;98(4):1252-1254. 1999;111(5):700-706.
61. Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme 77. McCrae KR, Herman JH. Posttransfusion purpura: two unusual
GA, Horsewood P. Immunoglobulin G from patients with cases and a literature review. Am J Hematol. July 1996;52(3):
heparin-induced thrombocytopenia binds to a complex of 205-211.
heparin and platelet factor 4. Blood. June 1, 1994;83(11):3232-3239. 78. Taaning E, Svejgaard A. Post-transfusion purpura: a survey
62. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 com- of 12 Danish cases with special reference to immunoglobulin
plexed to heparin is the target for antibodies generated in G subclasses of the platelet antibodies. Transfus Med. March
heparin-induced thrombocytopenia. Thromb Haemost. July 6, 1994;4(1):1-8.
1992;68(1):95-96. 79. Becker T, Panzer S, Maas D, et al. High-dose intravenous
63. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz immunoglobulin for post-transfusion purpura. Br J Haematol.
M. Role of platelet surface PF4 antigenic complexes in heparin- September 1985;61(1):149-155.
induced thrombocytopenia pathogenesis: diagnostic and thera- 80. Mueller-Eckhardt C, Kiefel V. High-dose IgG for post-
peutic implications. Blood. March 15, 2006;107(6):2346-2353. transfusion purpura-revisited. Blut. October 1988;57(4):163-167.
64. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced 81. Cines DB, Blanchette VS. Immune thrombocytopenic purpura.
thrombocytopenia. N Engl J Med. April 26, 2001;344(17): N Engl J Med. March 28, 2002;346(13):995-1008.
1286-1292. 82. George JN. Diagnosis, clinical course, and management of
65. Martel N, Lee J, Wells PS. Risk for heparin-induced throm- idiopathic thrombocytopenic purpura. Curr Opin Hematol.
bocytopenia with unfractionated and low-molecular-weight September 1996;3(5):335-340.
heparin thromboprophylaxis: a meta-analysis. Blood. October 83. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombo-
15, 2005;106(8):2710-2715. cytopenic purpura: a practice guideline developed by explicit
66. Bhatt VR, Aryal MR, Shrestha R, Armitage JO. Fondaparinux- methods for the American Society of Hematology. Blood. July 1,
associated heparin-induced thrombocytopenia. Eur J Haematol. 1996;88(1):3-40.
November 2013;91(5):437-441. 84. Ghadaki B, Nazi I, Kelton JG, Arnold DM. Sustained remis-
67. Muslimani AA, Ricaurte B, Daw HA. Immune heparin-induced sions of immune thrombocytopenia associated with the use
thrombocytopenia resulting from preceding exposure to hepa- of thrombopoietin receptor agonists. Transfusion. November
rin catheter flushes. Am J Hematol. July 2007;82(7):652-655. 2013;53(11):2807-2812.
68. Warkentin TE, Kelton JG. A 14-year study of heparin-induced 85. Imbach P, Crowther M. Thrombopoietin-receptor agonists for
thrombocytopenia. Am J Med. November 1996;101(5):502-507. primary immune thrombocytopenia. N Engl J Med. August 25,
69. Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler 2011;365(8):734-741.
P, Greinacher A. Gender imbalance and risk factor interactions 86. Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin
in heparin-induced thrombocytopenia. Blood. November 1, mutations in atypical hemolytic-uremic syndrome. N Engl J
2006;108(9):2937-2941. Med. July 23, 2009;361(4):345-357.
70. Arepally GM, Ortel TL. Clinical practice. Heparin-induced throm- 87. Rock G, Clark WF, Anderson D, et al. ADAMTS13 may
bocytopenia. N Engl J Med. August 24, 2006;355(8):809-817. not predict disease or outcome in patients with Thrombotic
71. Kelton JG, Arnold DM, Bates SM. Nonheparin anticoagulants Thrombocytopenic Purpura. Thromb Res. April 2013;131(4):
for heparin-induced thrombocytopenia. N Engl J Med. February 308-312.
21, 2013;368(8):737-744. 88. Camilleri RS, Scully M, Thomas M, et al. A phenotype-
72. Linkins LA, Dans AL, Moores LK, et al. Treatment and preven- genotype correlation of ADAMTS13 mutations in congenital
tion of heparin-induced thrombocytopenia: Antithrombotic thrombotic thrombocytopenic purpura patients treated in the
Therapy and Prevention of Thrombosis, 9th ed: American United Kingdom. J Thromb Haemost. September 2012;10(9):
College of Chest Physicians Evidence-Based Clinical Practice 1792-1801.
Guidelines. Chest. February 2012;141(2 suppl):e495S-e530S. 89. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of
73. Crowther MA, Cook DJ, Albert M, et al. The 4Ts scoring the ADAMTS gene family cause thrombotic thrombocytopenic
system for heparin-induced thrombocytopenia in medical- purpura. Nature. October 4, 2001;413(6855):488-494.
surgical intensive care unit patients. J Crit Care. June 2010;25(2): 90. Tsai HM, Lian EC. Antibodies to von Willebrand factor-
287-293. cleaving protease in acute thrombotic thrombocytopenic
74. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher purpura. N Engl J Med. November 26, 1998;339(22):1585-1594.
A. Evaluation of pretest clinical score (4 T's) for the diagnosis 91. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic
of heparin-induced thrombocytopenia in two clinical settings. purpura—report of 16 cases and review of literature. Medicine.
J Thromb Haemost. April 2006;4(4):759-765. 1966;45(2):139.
75. Cuker A, Gimotty PA, Crowther MA, Warkentin TE. 92. Vesely SK, George JN, Lammle B, et al. ADAMTS13 activity
Predictive value of the 4Ts scoring system for heparin-induced in thrombotic thrombocytopenic purpura-hemolytic uremic

Section07-O-ref.indd 3 1/21/2015 11:26:47 AM